Historically, it takes an average of 17 years to move new treatments from clinical evidence to daily practice. Given the highly effective treatments now available to prevent or delay kidney disease onset and progression, this is far too long. The time is now to narrow the gap between what we...
The mechanisms and relationship between acute pancreatitis and ASCVD are illustrated inFigure 2. Figure 2.Acute pancreatitis is associated with an elevated risk of acute ASCVD, ACS, MI, and cardiac injury. Potential mechanisms involve the release of inflammatory cytokines, which can lead to endothelia...